MRVI / Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q2 2022 Results - Earnings Call Transcript

SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and servi more_horizontal

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2023 Earnings Call Transcript August 7, 2023 5:00 PM ET Company Participants Debra Hart - Head o more_horizontal

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Deb Hart - Head of Inv more_horizontal

Maravai LifeSciences Holdings, Inc. (MRVI) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per shar more_horizontal

Long-term investments in biotech tend to be hard to come by. Moderna's gargantuan pipeline means that it has a very long growth runway ahead. more_horizontal

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Debra Hart - Hea more_horizontal

Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 2.94% and 0.30%, respectively, for the quarter ended December 2 more_horizontal

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2022 Results Conference Call November 2, 2022 5:00 PM ET Company Participants Deb Hart - Head of more_horizontal